细分的脂类瘤和非细分的脂类瘤:两个兄弟瘤的全身治疗选择
A Kyriazoglou1, A Pagkali1, I Kotsantis1
1Section of Medical Oncology, 2nd Department of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
Cancer treatment reviews
|March 16, 2024
概括
对微分化脂类肉瘤 (WDLPS) 和微分化脂类肉瘤 (DDLPS) 的全身治疗具有挑战性. 本综述讨论了当前的系统选择及其对这些具有挑战性的脂类瘤的临床疗效.
科学领域:
- 在瘤学瘤学.
- 医学遗传学 医学遗传学
- 药理学 药理学是指药理学的学科.
背景情况:
- 区分良好的脂类肉瘤 (WDLPS) 和非区分的脂类肉瘤 (DDLPS) 代表异质软组织肉瘤,占所有脂类肉瘤的60%.
- WDLPS和DDLPS都具有MDM2和CDK4基因的特征性遗传放大,突出了一个具有诊断和治疗意义的关键分子事件.
- 尽管有最佳的外科边缘和术后治疗,局部WDLPS和DDLPS的复发率显著 (25-30%),强调需要有效的全身疗法.
研究的目的:
- 审查和讨论诊断为WDLPS和DDLPS的患者可用的全身治疗选择.
- 分析和介绍用于管理这些脂质瘤亚型的各种全身疗法报告的临床疗效.
- 为WDLPS和DDLPS系统治疗提供当前挑战和治疗环境的概述.
主要方法:
- 对WDLPS和DDLPS系统性治疗选择的文献综述.
- 从已发表的研究中分析报告的临床疗效数据.
- 讨论基于当前证据的治疗策略.
主要成果:
- 目前,人环素被认为是WDLPS和DDLPS一线全身治疗的黄金标准.
- 已经研究了各种系统性治疗方案,但许多只显示了适度的疗效.
- 治疗复发性或转移性疾病仍然是一个重大的临床挑战.
结论:
- 对WDLPS和DDLPS的系统治疗仍然是瘤学中一个复杂的领域.
- 需要进一步的研究来确定更有效的全身疗法,以改善这些脂类瘤患者的治疗结果.
- 了解分子驱动因素,如MDM2和CDK4放大,可以指导未来的治疗开发.
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


